Laurion Capital Management’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-171,543	Closed	-$877K	–	651
2019 Q1	$877K	Buy	171,543 +77,145	+82%	+$394K	0.01%	304
2018 Q4	$324K	Buy	+94,398	New	+$324K	0.01%	436